Is this you? Create Your Porfile
Avatar

James R. Paterniti

Amylin Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where James R. Paterniti is active.

Explore More

Publication

Featured researches published by James R. Paterniti.

Bioorganic & Medicinal Chemistry Letters | 2002

Thiourea-based gemfibrozil analogues as HDL-elevating agents.

Gary Mark Coppola; Robert E. Damon; J. Bruce Eskesen; James R. Paterniti

A series of gemfibrozil analogues with a thiourea moiety embedded in the side chain was prepared and evaluated as HDL-elevating agents. Derivatives 8b, 9b, 9c, and 9d were found to be approximately as effective as gemfibrozil (1) for HDL cholesterol elevation.

Endocrinology | 2004

Effects of Peptide YY[3–36] on Short-Term Food Intake in Mice Are Not Affected by Prevailing Plasma Ghrelin Levels

Sean H. Adams; Wesley Won; Susan Schonhoff; Andrew B. Leiter; James R. Paterniti

Archive | 2003

Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof

Bronislava Gedulin; Andrew A. Young; James R. Paterniti

Bioorganic & Medicinal Chemistry Letters | 2005

1-Hydroxyalkyl-3-phenylthioureas as novel HDL-elevating agents

Gary Mark Coppola; Robert E. Damon; J. Bruce Eskesen; James R. Paterniti

Archive | 2001

Methods of treating obesity using PYY[3-36]

Richard A. Pittner; Andrew A. Young; James R. Paterniti

Bioorganic & Medicinal Chemistry Letters | 2006

Biological evaluation of 1-alkyl-3-phenylthioureas as orally active HDL-elevating agents

Gary Mark Coppola; Robert E. Damon; J. Bruce Eskesen; James R. Paterniti

Archive | 2003

Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü

Bronislava Gedulin; Andrew A. Young; James R. Paterniti

Archive | 2003

Prävention und/oder behandlung von colitis ulcerosa mit pyy oder pyyä3-36ü Prevention and / or treatment of ulcerative colitis with PYY or pyyä3-36ü

Bronislava Gedulin; Andrew A. Young; James R. Paterniti

Archive | 2003

Prevention et/ou traitement de maladie enterique inflammatoire au moyen de peptides yy ou d'antagonistes de peptides yy

Bronislava Gedulin; Andrew A. Young; James R. Paterniti

Archive | 2001

Peptide yy et antagonistes de peptides yy destines au traitement des troubles du metabolisme

Richard A. Pittner; Andrew A. Young; James R. Paterniti

Explore More

Collaboration

Dive into the James R. Paterniti's collaboration.

Top Co-Authors
Avatar

Andrew A. Young

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

Bronislava Gedulin

Amylin Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Richard A. Pittner

Amylin Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

J. Bruce Eskesen

Novartis

View shared research outputs
Top Co-Authors
Avatar

Robert E. Damon

Novartis

View shared research outputs
Top Co-Authors
Avatar

Gary Mark Coppola

Novartis

View shared research outputs
Top Co-Authors
Avatar

Andrew B. Leiter

University of Massachusetts Medical School

View shared research outputs
Top Co-Authors
Avatar

Sean H. Adams

Amylin Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Susan Schonhoff

Tufts Medical Center

View shared research outputs
Top Co-Authors
Avatar

Wesley Won

Amylin Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge